Abstract:Introduction Stroke is a major cause of permanent neurologic damage, with few effective treatments available to restore lost function. Induced pluripotent stem cells (iPSCs) have the potential to generate all cell types in vitro and can be generated from a stroke patient. Therefore, iPSCs are attractive donor sources of genetically identical “patient-specific” cells to hold promise in therapy for stroke. In the present study, we established a four-stage culture system by using serum-free medium and retinoic acid (RA) to differentiate iPSCs into neural stem cells (NSCs) effectively and stably. Our hypothesis was that iPSC-derived NSCs would survive, migrate, and differentiate in vivo , and improve neurologic function after transplantation into the brains of rats with ischemic stroke. Methods Human iPSCs (iPS-S-01) and human ESCs (HuES17) were used to differentiate into NSCs by using our four-stage culture system. iPSCs and differentiated NSCs were characterized by immunocytochemistry staining and reverse transcription-polymerase chain reaction (RT-PCR) analysis. After establishment of focal cerebral ischemia with occlusion of the middle cerebral artery (MCA) and cell transplantation, animals were killed at 1 week and 2 weeks to analyze survival, migration, and differentiation of implanted cells in brain tissue. Animal behavior was evaluated via rope grabbing, beam walking, and Morris water maze tests. Results iPSCs were efficiently induced into NSCs by using a newly established four-stage induction system in vitro . iPSCs expressed pluripotency-associated genes Oct4 , Sox2 , and Nanog before NSC differentiation. The iPSC-derived NSCs spontaneously differentiated into neurons and astrocytes, which highly express β-tubulin and glial fibrillary acidic protein (GFAP), respectively. On transplantation into the striatum, CM-DiI labeled iPSC-derived NSCs were found to migrate into the ischemia area at 1 week and 2 weeks, and animal-function recovery was significantly improved in comparison with control groups at 3 weeks. Conclusions The four-stage induction system is stable and effective to culture, differentiate, and induce iPSCs to NSCs by using serum-free medium combined with retinoic acid (RA). Implanted iPSC-derived NSCs were able to survive, migrate into the ischemic brain area to differentiate into mature neural cells, and seem to have potential to restore lost neurologic function from damage due to stroke in a rat model.

Induced Pluripotent Stem Cell-Derived Neural Progenitor Cell Transplantation Promotes Regeneration and Functional Recovery after Post-Traumatic Stress Disorder in Rats.

11 C-NMSP/ 18 F-FDG Micropet to Monitor Neural Stem Cell Transplantation in a Rat Model of Traumatic Brain Injury

Functional recovery after transplantation of neural stem cells modified by brain-derived neurotrophic factor in rats with cerebral ischaemia

Intracranial Transplantation of Hypoxia-Preconditioned iPS Cell-derived Neural Progenitor Cells Alleviates Neuropsychiatric Defects after Traumatic Brain Injury in Juvenile Rats.

Pet Demonstrates Functional Recovery after Transplantation of Induced Pluripotent Stem Cells in A Rat Model of Cerebral Ischemic Injury

Transplanted Human Neural Precursor Cells Integrate into the Host Neural Circuit and Ameliorate Neurological Deficits in a Mouse Model of Traumatic Brain Injury

Neural Stem Cell Transplants Improve Cognitive Function Without Altering Amyloid Pathology in an App/Ps1 Double Transgenic Model of Alzheimer'S Disease

Transplantation of Human Urine-Derived Neural Progenitor Cells after Spinal Cord Injury in Rats

Ipsc Transplantation Increases Regeneration and Functional Recovery after Ischemic Stroke in Neonatal Rats

Neural Stem Cell Transplantation Promotes Functional Recovery from Traumatic Brain Injury via Brain Derived Neurotrophic Factor-Mediated Neuroplasticity

Human induced pluripotent stem cell/embryonic stem cell-derived pyramidal neuronal precursors show safety and efficacy in a rat spinal cord injury model

Tracking Induced Pluripotent Stem Cells-Derived Neural Stem Cells in the Central Nervous System of Rats and Monkeys.

Spatiotemporal Pet Imaging Of Dynamic Metabolic Changes After Therapeutic Approaches Of Induced Pluripotent Stem Cells, Neuronal Stem Cells, And A Chinese Patent Medicine In Stroke

Human-Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Showed Neuronal Differentiation, Neurite Extension, and Formation of Synaptic Structures in Rodent Ischemic Stroke Brains

Transplantation of iPS cell-derived neural progenitors overexpressing SDF-1α increases regeneration and functional recovery after ischemic stroke.

Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion

Human-Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Limits Tissue Damage and Promotes Tissue Regeneration and Functional Recovery in a Pediatric Piglet Traumatic-Brain-Injury Model

Nerve Growth Factor Against PTSD Symptoms: Preventing the Impaired Hippocampal Cytoarchitectures

PSA-NCAM+ Neural Precursor Cells from Human Embryonic Stem Cells Promote Neural Tissue Integrity and Behavioral Performance in A Rat Stroke Model

Rehabilitative Training Enhances Therapeutic Effect of Human iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury

Three Growth Factors Induce Proliferation and Differentiation of Neural Precursor Cells In Vitro and Support Cell-Transplantation after Spinal Cord Injury In Vivo